谷歌浏览器插件
订阅小程序
在清言上使用

Response Adaptive Salvage Treatment with Carfilzomib-ThalidomideDexamethasone for Newly Diagnosed Transplant Eligible Multiple Myeloma Patients Failing Front-Line BortezomibBased Induction Therapy - Final Analysis from the Australasian Leukemia and Lymphoma Group (ALLG) MM17 Trial

BLOOD(2021)

引用 1|浏览13
暂无评分
摘要
BACKGROUND
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要